It#8217s the oldest negotiating trick in the book: If you come off the starting block with an outlandish offer, any capitulation feels comparatively reasonable.
After raising the list price of EpiPen, the life-saving severe allergy medication and application device, by 500% in the last ten yearsmdashfrom $100 for a two-pack in 2007 to more than $600 in 2016mdashthe drug company Mylan announced today that it would roll out a new, generic version of its branded drug for just $300 per two-pack for commercially-insured patients.
That#8217s a 200% increase in price since 2008, rather than a 500% one.
#8220Our decision to launch a generic alternative to EpiPen is an extraordinary commercial response,#8221 Mylan CEO Heather Bresch said in a statement.The Brief Newsletter Sign up to receive the top stories you need to know right now. View Sample Sign Up Now
The announcement comes after a month of public outrage over the rising price of EpiPens, with lawmakers, Democratic presidential nominee Hillary Clinton, and former Mylan spokeswoman Sarah Jessica Parker accusing the company of price gouging. Netherlands-based Mylan saw its stock fall 12% last week.
On August 25, Mylan it would also expand its patient assistance program, which provides coupons and discounts to patients whose household incomes are four times the poverty level.
The company#8217s generic version of the branded EpiPen is set to launch #8220in several weeks#8221 and will be listed at 50% the price of the branded version, which has a sticker price of $609 per two-pack. Aside from the cost, the generic version will be #8220identical to the branded product, including device functionality and drug formulation.#8221
Mylan said it also intends to continue to market and distribute branded EpiPen. Because of the convoluted way that drugs are paid formdashinsurers pay a negotiated price on certain drugs, consumers pay co-pays and insurance, drug companies provide discount couponsmdashsome insurance companies will continue to cover the branded EpiPen, in addition to the generic version, even though the drugs are the same.
Patients with commercial insurance will need to apply for a $300 savings card to access the generic EpiPen. The #8220My EpiPen Savings Cardreg,#8221 as its called on the company#8217s website, will then #8220act as cash#8221 at the pharmacy, bringing down the cost of a patient#8217s co-pay for a two-pack of EpiPens to no more than $300. Patients can use the savings cards on up to six two-packs a year.(责任编辑：彩票代购网站源码) 本文地址：http://www.troxtabo.com/qinggan/yinsi/201908/3291.html